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Serosurveillance for Japanese encephalitis virus infection among 
equines in India
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National Research Centre on Equines, Sirsa Road, Hisar-125001, Haryana, India
The seroprevalence of Japanese encephalitis virus (JEV) 
among  equines  was  evaluated  from  January  2006  to 
December  2009  in  13  different  states  of  India  by 
hemagglutination inhibition (HI) test and virus neutrali-
zation test (VNT). Antibodies against JEV were detected in 
327 out of 3,286 (10%) equines with a maximum prevalence 
reported  in  the  state  of  Manipur  (91.7%)  followed  by 
Gujarat  (18.5%),  Madhya  Pradesh  (14.4%),  and  Uttar 
Pradesh (11.6%). Evidence of JEV infection was observed in 
equines  in  Indore  (Madhya  Pradesh)  where  a  4-fold  or 
higher rise in antibody titer was observed in 21 out of 34 
horses in November 2007 to October 2006. In March 2008, 
seven of these horses had a subsequent 4-fold rise in JEV 
antibody titers while this titer decreased in nine animals. 
JEV-positive horse sera had a JEV/WNV (West Nile virus) 
ratio over 2.0 according to the HI and/or VNT. These results 
indicated that JEV is endemic among equines in India.
Keywords: equines, haemagglutination inhibition, Japanese 
encephalitis virus, serosurveillance, virus neutralization
Introduction
Japanese encephalitis (JE) is a mosquito-transmitted viral 
disease caused by the JE virus (JEV) belonging to the 
genus  Flavivirus and family Flaviviridae. JEV is an 
enveloped virus with plus-sense, single-stranded RNA 
about 11 kb in length with a single open reading frame 
(ORF) encoding a polyprotein of approximately 3,400 
amino acids. This peptide is subsequently cleaved into 
three structural and seven non-structural proteins [2]. JEV 
causes disease in equines, pigs, and humans. It is prevalent 
in eastern and southern Asia, and has spread to Indonesia, 
northern Australia, Papua New Guinea, and Pakistan [18]. 
Approximately 3 billion people live in JEV-endemic areas 
where 50,000 clinical cases and 15,000 human deaths due 
to JE are reported annually [8]. The virus may infect a 
number of other domestic animals including cattle, sheep, 
goat, dogs and cats, although these infections are typically 
asymptomatic.
Equines infected with JEV may develop clinical signs 
such as fever, anorexia, depression, impaired locomotion, 
impaired vision, paresis, and paralysis. The affected horse 
may collapse, fall in a coma and eventually die. Rates of 
mortality due to JE range between 5% and 30%. Sporadic 
cases of JE in horses have been reported in various 
countries, including Japan [13,25], Hong Kong [14], and 
Taiwan [15]. In addition, JE seropositivity among equines 
has been reported in Nepal [19] and Indonesia [24]. 
According to the 2007 Livestock Census, there are 
1,186,000 equines including horses, ponies, mules and 
donkeys in India [5]. Since equines are not vaccinated 
against JE in India, these animals are potentially at risk, 
especially in states where JE outbreaks in humans have 
been reported [6]. There have been a few isolated reports 
describing JEV seropositivity in equines in India 
[3,7,10,16,21-23].
With global warming, changing agricultural practices and 
increases in vector populations, there has been rise in JE 
incidence among humans in India during the last decade. 
This disease has been reported in human populations in the 
states of Andhra Pradesh, Assam, Bihar, Goa, Haryana, 
Karnataka, Kerala, Mahrashtra, Manipur, Tamil Nadu, 
Uttar Pradesh, West Bengal, and Nagaland [6,20]. 
However, prevalence of JE among equines in India has not 
been reported during the last decade. This paper describes 
the serological evidence of JEV infection among equines 
in different states of India.
Materials and Methods
Collection of samples 
For the seroprevalence study, blood samples from 
indigenous equines in various states of India were 
collected between January 2006 and December 2009. 
None of the horses included in this study had been 
vaccinated against JEV. Blood samples were stored at 4
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Table 1. Seroprevalence of Japanese encephalitis virus in 
equines from 2006 to 2009 according to states
State Tested Positive Percent 
Haryana
Madhya Pradesh
Chattisgarh
Rajasthan
Manipur
Gujarat
Himachal Pradesh
Jammu & Kashmir
Uttar Pradesh
Sikkim
Punjab
Karnataka
Uttarakhand
342
620
105
626
48
168
107
491
329
32
100
109
209
35
89
8
49
44
31
0
0
38
0
3
10
20
10.2
14.4
　7.6
　7.8
91.7
18.5
　0.0
　0.0
11.6
　0.0
　3.0
　9.2
　9.6
Total 3,286 327
after collection until they were transported to the 
laboratory. Serum was separated by centrifugation at 1,000 
× g for 5 min and stored at 򰠏30
oC until further use. Equine 
serum samples collected from horses in Manipur during 
March 2003 and April 2005 and available in the Serum 
Bank of National Research Centre on Equines (Hisar, 
India) were also included in the study.
Viruses and cells
JEV (strain P20778) and West Nile virus (WNV; strain 
G22886) were obtained from the National Institute of 
Virology, Pune (India). The viruses were propagated in 
Swiss albino suckling mice via intra-cerebral inoculation 
and porcine stable kidney (PS) cells procured from 
National Centre for Cell Sciences, India. The PS cells were 
grown at 37
oC in Eagle’s minimal essential medium 
(EMEM) supplemented with 10% fetal bovine serum 
(FBS), 100 IU/mL penicillin, 100 μg/mL streptomycin, 
and 0.25 μg/mL amphotericin-B (Sigma-Aldrich, USA).
Hemagglutination inhibition (HI) test
HI test was carried out in duplicate in 96-well microplates 
using 8 hemagglutinating antigen (HA) units/25 μL of 
sucrose-acetone extracted antigen prepared from the brains 
of suckling mice infected with JEV or WNV as described 
previously [4]. Serum samples were treated with cold 
acetone to remove non-specific HA inhibitors and were 
absorbed with goose erythrocytes [4]. Hyper-immune 
serum to both JEV and WNV previously raised in rabbits 
by inoculating inactivated purified viruses, were included 
in each test as positive controls. HI titers were expressed as 
the reciprocal of the highest dilution of the serum that 
completely inhibited haemagglutination. An HI titer of 20 
and above was considered positive.
Virus neutralization test (VNT)
Serial two-fold dilutions of JEV and WNV (four wells per 
dilution per virus) in 100 μL volume of EMEM supplemented 
with 2% FBS were made in 96-well culture plates. To each 
well, 100 μL of PS cells (2 × 10
5 cells/mL in EMEM 
supplemented with 10% FBS) were added and incubated 
for 5 days at 37
oC in 5% CO2. The wells showing 
cytopathic effects (CPE) were recorded to calculate 50% 
tissue culture infectivity dose (TCID50) of both the viruses. 
VNT was performed in 96-well tissue culture plates using 
PS cells. Serum samples were heat inactivated at 56
oC for 
30 min and serial two-fold dilutions of the serum in a 50 μL 
volume was mixed with an equal volume of 300 TCID50 of 
the JEV or WNV. After incubating the virus-serum mixture 
at 37
oC for 1 h, 100 μL of a PS cell suspension (2 × 10
5 
cells/mL) was added to each well. The plates were 
incubated at 37
oC in 5% CO2 for 5 days and CPE in each 
well was recorded. The neutralization titers were 
expressed as the reciprocal of the highest serum dilution 
that completely inhibited CPE in the wells. Titers of 4 and 
above were considered positive.
Statistical analysis
Chi-squared test was used to analyze differences in JEV 
seroprevalence between states and years. A p-value less 
than 0.05 was considered to be statistically significant.
Results
JEV seroprevalence
We conducted a JEV serosurveillance study in equines in 
13 states of India including Jammu & Kashmir (J&K), 
Himachal Pradesh, Punjab, Haryana, Rajasthan, Gujarat, 
Uttarakhand, Uttar Pradesh, Madhya Pradesh, Chhattisgarh, 
Karnataka, Sikkim and Manipur. Out of 3,286 equine 
serum samples tested, 327 (10%) were positive for JEV 
antibodies according to both HI and VNT results (Table 1). 
No significant differences in JEV sero-prevalence were 
observed from year to year between 2006 and 2009 (Table 
2). However, differences (p ＜ 0.05) in JEV positivity 
among different states were observed (Table 1). None of 
the equines from the northern hill states of J&K, Himachal 
Pradesh, or Sikkim were positive for JEV antibodies. The 
maximum JEV seroprevalence was recorded in Manipur (a 
north-eastern state of India) where 91.7% (44 out of 48) 
equines were positive, followed by Gujarat (18%) and 
Madhya Pradesh (14.4%).
Serum samples from two adjoining equine farms in 
Indore (Madhya Pradesh) with a total of 34 horses have 
been collected annually since 2005. In 2005, all horses 
from these farms tested negative for JEV antibodies while Japanese encephalitis among equines in India    343
Table 2. Seroprevalence of Japanese encephalitis virus in 
equines from 2006 to 2009 according to years 
Year Tested Positive Percent 
2006
2007
2008
2009
　729
　808
　889
　860
109
　46
　71
101
14.9
　5.7
　8.0
11.7
Total 3,286 327
Table 3. Seroprevalence of Japanese encephalitis virus among 
horses (n = 34) from Indore (Madhya Pradesh) between 2006 and 
2008
Hemagglutination
inhibition titer*
No. of samples with titers 
collected from horses 
November 
2006
November 
2007
March
 2008
October
 2008
＜20
20∼40
80∼160
320 and above
Not tested
21
　2
　0
　0
11
13
　6
14
　1
　0
　5
12
15
　1
　1
22
　8
　4
　0
　0
*Titers are expressed as the reciprocal of the highest dilution of 
serum. Titers for haemagglutination inhibition 20 and above were 
considered positive.
Table 4. Hemagglutination inhibition and virus neutralization titersa gainst Japanese encephalitis virus (JEV) and West Nile virus 
(WNV) in equine serum samples collected from Indore (Madhya Pradesh) in November 2007
Sample no.
Hemagglutination inhibition results Virus neutralization results
JEV WNV JEV/WNV JEV WNV JEV/WNV
1
2
3
4
5
7
8
9
13
14
15
16
17
18
19
22
24
26
27
28
32
80
40
160
40
80
160
160
320
40
40
40
80
160
160
80
160
40
160
160
80
80
10
10
40
40
20
40
40
40
10
10
10
10
40
40
10
40
10
40
40
10
20
8
4
4
1
4
4
4
8
4
4
4
8
4
4
8
4
4
4
4
8
4
16
16
16
16
16
16
16
32
8
8
8
16
32
32
32
32
8
32
32
16
16
2
2
4
2
2
2
2
4
4
2
8
4
4
8
8
8
4
8
8
4
8
8
8
4
8
8
8
8
8
2
4
1
4
8
4
4
4
2
4
4
4
2
*Titers are expressed as the reciprocal of the highest dilution of serum. Titers for hemagglutination inhibition 20 and above along with virus 
neutralization titers of 4 and above were considered positive.
only two horses in November 2006 were positive with an 
HI titer of 40 and a VNT titer of 4. However, in November 
2007, 21 horses from these two farms were significantly 
positive with HI titers of 20∼40 (n = 6), 80∼160 (n = 14), 
or 320 or above (n = 1). There were 28 positive horses in 
March 2008. Out of these, seven showed a 4-fold rise and 
nine showed a 4-fold decline in JEV antibody titers 
according to the HI test and VNT compared to the results 
from November 2007. JEV antibody titers declined in the 
positive horses by October 2008 (Table 3). Some of these 
animals were anorectic and pyretic in October 2007 (rectal 
temperature around 38.9
oC) for 2∼3 days although no 344    Baldev R. Gulati et al.
neurological signs or mortality were reported in these 
farms.
Cross-reactivity of the JEV-positive equine sera from 
Indore (Madhya Pradesh) with WNV was evaluated. All 
the 21 positive equine samples collected from Indore in 
November 2007 had JEV HI titers between 40 and 320. 
Twelve of these also had WNV HI titers between 20 and 40 
(Table 4). Similarly, the 21 equine samples had JEV VN 
titers between 8 and 32. Out of these, 12 horses had 
neutralizing antibodies against WNV with VN titers 
between 2 and 8. However, the JEV titer/WNV titer ratios 
were 4 and above for 20 out of 21 horses according to the 
HI test, while the VNT showed that 17 out of the 21 horses 
had JEV/WNV ratios of 4 and above (Table 4).
Since maximum sero-positivity was observed in equines 
from Manipur, serum samples from equines in the state of 
Manipur collected in March 2003 (n = 71) and April 2005 
(n = 35) and archived at the Serum Bank of National 
Research Centre on Equines were also tested for JEV 
antibodies. Only two out of 71 (2.8%) equines in March 
2003 and 14 out of 35 (35%) equines in April 2005 were 
positive for JEV antibodies. However, 91.7% of equines in 
Manipur were positive in March 2007.
Discussion
JE remains endemo-epidemic in several Asian countries. 
Several outbreaks among humans and domestic animals 
are reported every year in different regions of the world. 
Sporadic cases of JE in horses have been observed in Japan 
[12,25], Hong Kong [14], and Korea [15] despite the use of 
JEV vaccinations in these countries. JEV outbreaks have 
been reported in humans from 24 states/Union Territories 
of India. In northern India, large epidemics of JE occur 
during summer whereas in the southern region JE tends to 
be endemic throughout the year [17]. Out of 3,286 equines 
in 13 states in India, 10% were positive for JEV antibodies 
according to our sero-surveillance. In India, vaccination 
against JEV is not performed in equines. There have been 
a few isolated reports describing sero-positive equines in 
India [3,7,10,16,21-23]; however, the present study is the 
first report of JEV sero-surveillance of equines from 13 
different states.
Based on seroconversion, it was apparent that JEV 
infection occurred in two farms in Indore (Madhya 
Pradesh) during October 2007 when some horses were 
reported to be anorectic and pyretic for 2∼3 days although 
no neurological signs or mortality were observed. 
Attempted virus isolation and RT-PCR detection of viral 
RNA in serum samples from these horses were not 
successful (data not shown). In horses, most JEV 
infections remain sub-clinical and the only symptom may 
be fever and a short period of lethargy [17].
Serodiagnosis is primarily used for JEV surveillance 
because virus isolation from JEV-infected horses is 
difficult due to transient viremia and low virus titers 
[9,16,17]. HI test, VNT, and ELISA are commonly used for 
sero-diagnoses of JEV. However, cross-reactivity with 
related flaviviruses, including WNV, has been observed in 
these assays. WNV infection in horses has not been 
documented in India although it is circulating among 
humans and animals in this country [1]. Therefore, it is 
critical to distinguish between JEV and WNV in areas 
where both viruses are endemic. When sera are tested for 
both antigens, an animal is considered positive for the virus 
that shows a 2-4-fold higher antibody titer. JEV infection 
in horses from Indore (Madhya Pradesh) was confirmed by 
demonstration of a JEV titer/WNV titer ratio that was 4 and 
above according to either the HI test or VNT, indicating 
that these animals were in fact infected with JEV and not 
with WNV [11].
In the present study, more than 90% of equines tested in 
the north-eastern state of Manipur were JEV-positive in 
March 2007. Manipur has an indigenous breed of equine, 
called Manipuri ponies, which are used for playing polo. 
Our retrospective study of archived sera revealed that only 
2% of the equines in Manipur were sero-positive for JEV in 
March 2003. However, the rate of sero-positivity rose to 
35% in April 2005 and 90% in 2007. It should be 
mentioned that human JEV infection is endemic in the 
North-Eastern states of India and human deaths due to JEV 
have been reported from the state of Manipur during last 5 
years. Our findings indicate that these animals were 
sub-clinically infected after 2003, making them sero- 
positive, since no history of neurological illness was 
reported for these animals.
Due to changing agricultural practices (increased irrigation 
facilities that provide mosquito breeding sites), expanding 
ranges for migratory birds (like cattle egrets), and 
increased animal husbandry (pig rearing), JEV infection 
has been reported during last decade in newer areas of 
India, Nepal, and Australia. The JEV seroprevalence in 
horses we observed may have potential implications for the 
future spread of JEV in equine populations, resulting in 
increased morbidity and mortality in these animals. In 
addition, JEV may also spread via mosquito vectors to 
humans and other animal population in 10 out of the 13 
states where JEV sero-positivity in horses has been 
reported in the present study [6,17,20].
Along with a ‘One Health’ approach for collectively 
combating JEV infection in human-animal interface, 
additional surveys of animal, human, and vector populations 
are necessary to understand the effects of climate changes 
on JEV distribution and disease transmission via vectors. 
This will provide better assessment of the risks posed by 
JEV which will, in turn, help to establish strategies for 
effective control and management of this virus.Japanese encephalitis among equines in India    345
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